Trelegy Ellipta vs Jakafi
Side-by-side drug price comparison from Medicare Part D data
Verdict
Trelegy Ellipta costs 97% less per claim than Jakafi ($380.00 vs $11432.00). Neither drug has a generic alternative available. Total Medicare spending: Trelegy Ellipta at $2.9B vs Jakafi at $2.7B.
| Metric | Trelegy Ellipta | Jakafi |
|---|---|---|
| Avg Cost per Claim Average cost Medicare pays per prescription claim | $380* | $11,432 |
| Total Medicare Spending Total Medicare Part D spending on this drug | $2.9B | $2.7B |
| Total Claims | 7,560,000 | 236,000 |
| Year-over-Year Change Price change from prior year (lower is better for patients) | 19.8% | 11.2%* |
| Generic Available | No | No |
| Condition | Asthma/COPD | Cancer |
| Total Beneficiaries | 865,000 | 22,000 |
Trelegy Ellipta costs 97% less per claim than Jakafi ($380.00 vs $11432.00). Neither drug has a generic alternative available. Total Medicare spending: Trelegy Ellipta at $2.9B vs Jakafi at $2.7B.